$0.04
(Market cap
$958 Mln
Revenue (TTM)
$2,674 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
21.3
-
Debt to Equity
1.4
-
Book Value
$--
-
EPS
$-15.4
-
Face value
--
-
Shares outstanding
68,575,427
10 Years Aggregate
CFO
$2,983.48 Mln
EBITDA
$4,047.22 Mln
Net Profit
$2,165.07 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Quidel (QDEL)
| -51.1 | -21.1 | 2.7 | -49.4 | -44.9 | -37.1 | -4.3 |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Quidel (QDEL)
| -35.9 | -39.3 | -14.0 | -24.9 | 139.4 | 53.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Quidel (QDEL)
|
14.0 | 958.0 | 2,674.2 | -1,048.4 | -30.3 | -56.7 | -- | 0.5 |
| 62.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 15.0 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 58.5 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 177.5 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 101.0 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 89.6 | 5,350.1 | 1,579.2 | 145.6 | 14.3 | 8.9 | 36.9 | 3.2 | |
| 322.2 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 167.6 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Quidel (QDEL)
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments... and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California. Read more
-
Interim CEO, Executive VP & Chief Commercial Officer
Mr. Michael S. Iskra
-
Interim CEO, Executive VP & Chief Commercial Officer
Mr. Michael S. Iskra
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Quidel (QDEL)
What is the current share price of Quidel Corporation (QDEL) Today?
The share price of Quidel Corporation (QDEL) is $13.97 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Quidel Corporation (QDEL) has given a return of -44.93% in the last 3 years.
What is the current PB & PE ratio of Quidel Corporation (QDEL)?
Since, TTM earnings of Quidel Corporation (QDEL) is negative, P/E ratio is not available.
The P/B ratio of Quidel Corporation (QDEL) is 0.54 times as on 04-Sep-2026, a 86 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.71 |
1.01 |
2024 |
-1.46 |
1.00 |
2023 |
-491.09 |
0.99 |
2022 |
10.45 |
1.16 |
2021 |
8.15 |
2.97 |
What is the 52 Week High and Low of Quidel Corporation (QDEL)?
The 52-week high and low of Quidel Corporation (QDEL) are Rs 35.58 and Rs 9.92 as of 06-Sep-2026.
What is the market cap of Quidel Corporation (QDEL)?
Quidel Corporation (QDEL) has a market capitalisation of $ 958 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Quidel Corporation (QDEL)?
Before investing in Quidel Corporation (QDEL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.